Do you want to read an article? Please log in or register.
Ultrasound in the assessment of interstitial lung disease in systemic sclerosis. A systematic literature review by the OMERACT Ultrasound Group
Systemic Sclerosis
Related content
Systemic SclerosisFurther Publications Rheumatology
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process
Semin Arthritis Rheum
Roofeh D, Barratt SL, Wells AU, Kawano-Dourado L, Tashkin D, Strand V, Seibold J, Proudman S, Brown KK, Dellaripa PF, Doyle T, Leonard T, Matteson EL, Oddis CV, Solomon JJ, Sparks JA, Vassallo R, Maxwell L, Beaton D, Christensen R, Townsend W, Khanna D
doi: 10.1016/j.semarthrit.2021.08.001
Systemic Lupus Erythematosus
Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group
J Rheumatol.
Wong PC, Lee G, Sedie AD, Hanova P, Inanc N, Jousse-Joulin S, Ohrndorf S, Stoenoiu MS, Keen HI, Terslev L, D'Agostino MA, Bruyn GA
doi: 10.3899/jrheum.181087.
Further Publications Rheumatology
Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
Rheumatology (Oxford)
Goswami RP, Ray A, Chatterjee M, Mukherjee A, Sircar G, Ghosh P
doi: 10.1093/rheumatology/keaa550
Systemic Sclerosis
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
Rheumatology (Oxford).
Bonhomme O, André B, Gester F, de Seny D, Moermans C, Struman I, Louis R, Malaise M, Guiot J
doi: 10.1093/rheumatology/
EULAR ® 2019
Systemic Sclerosis-Associated Interstitial Lung Disease
Distler et al. 2019. Nintedanib reduced decline in forced vital capacity across subgroups of patients with systemic sclerosis-associated interstitial lung disease: Data from the SENSCIS trial. Oral presentation presented at: EULAR 2019 Congress; 12–15 June 2019; Madrid, Spain.
Systemic Sclerosis
Hemodynamic response to treatment and outcome in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis
Arthritis Rheumatol.
Chauvelot L, Gamondes D, Berthiller J, Nieves A, Renard S, Catella-Chatron J, Ahmad K, Bertoletti L, Camara B, Gomez E, Launay D, Montani D, Mornex JF, Prévot G, Sanchez O, Schott AM, Subtil F, Traclet J, Turquier S, Zeghmar S, Habib G, Reynaud-Gaubert M, Humbert M, Cottin V
doi: 10.1002/art.41512.
RECOMMENDED
Rheumatoid Arthritis
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J, Zou S
doi: 10.1186/s12931-021-01856-z
Systemic Sclerosis
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study
Rheumatology (Oxford)
Li Q, Wallace L, Patnaik P, Alves M, Gahlemann M, Kohlbrenner V, Raabe C, Wang JR, Garry EM
doi: 10.1093/rheumatology/keaa547
Further Publications Rheumatology
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Respirology
Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Chua F, Maher TM, Abraham DJ, Ong V, Donovan J, Sestini P, Denton CP, Wells AU, Renzoni EA
doi: 10.1111/resp.13988